$50 Million

Elevation Oncology, Inc.

Follow-on Offering

Bookrunner, June 2023

Elevation Oncology, Inc.

Elevation Oncology (“Elevation”) is an innovative oncology company focused on the discovery and development of selective cancer therapies to treat patients across a range of solid tumors with significant unmet medical needs. Elevation is rethinking drug development by seeking out innovative, selective cancer therapies that can be matched to a patient's unique tumor characteristics.